Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): Prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement.
Tognola C, Myriam Intravaia RC, Senini E, Pezzoli S, Riccio A, Gualini E, Fabbri S, Bellantonio V, Politi F, Campana M, Fucile I, Mancusi C, Golia E, Cesaro A, De Luca N, Calabrò P, Giannattasio C, Maloberti A. Tognola C, et al. Among authors: golia e. Nutr Metab Cardiovasc Dis. 2024 Aug 10:S0939-4753(24)00303-X. doi: 10.1016/j.numecd.2024.08.006. Online ahead of print. Nutr Metab Cardiovasc Dis. 2024. PMID: 39289142
Secondary Prevention and Extreme Cardiovascular Risk Evaluation (SEVERE-1), Focus on Prevalence and Associated Risk Factors: The Study Protocol.
Maloberti A, Intravaia RCM, Mancusi C, Cesaro A, Golia E, Ilaria F, Coletta S, Merlini P, De Chiara B, Bernasconi D, Algeri M, Ossola P, Ciampi C, Riccio A, Tognola C, Ardissino M, Inglese E, Scaglione F, Calabrò P, De Luca N, Giannattasio C. Maloberti A, et al. Among authors: golia e. High Blood Press Cardiovasc Prev. 2023 Nov;30(6):573-583. doi: 10.1007/s40292-023-00607-z. Epub 2023 Nov 30. High Blood Press Cardiovasc Prev. 2023. PMID: 38030852 Free PMC article.
Radial Versus Femoral Access for Coronary Angiography.
Calabro P, Golia E, Crisci M. Calabro P, et al. Among authors: golia e. Angiology. 2018 Apr;69(4):286-287. doi: 10.1177/0003319717693731. Epub 2017 Mar 2. Angiology. 2018. PMID: 29214864 No abstract available.
CRP and the risk of atherosclerotic events.
Calabrò P, Golia E, Yeh ET. Calabrò P, et al. Among authors: golia e. Semin Immunopathol. 2009 Jun;31(1):79-94. doi: 10.1007/s00281-009-0149-4. Epub 2009 May 5. Semin Immunopathol. 2009. PMID: 19415283 Review.
Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience.
Gragnano F, Natale F, Concilio C, Fimiani F, Cesaro A, Sperlongano S, Crisci M, Limongelli G, Calabrò R, Russo M, Golia E, Calabrò P. Gragnano F, et al. Among authors: golia e. J Cardiovasc Med (Hagerstown). 2018 Feb;19(2):75-77. doi: 10.2459/JCM.0000000000000611. J Cardiovasc Med (Hagerstown). 2018. PMID: 29251697 No abstract available.
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go.
Vergara A, De Felice M, Cesaro A, Gragnano F, Pariggiano I, Golia E, De Pasquale A, Blasi E, Fimiani F, Monda E, Limongelli G, Calabrò P. Vergara A, et al. Among authors: golia e. Angiology. 2024 Nov-Dec;75(10):909-920. doi: 10.1177/00033197231201929. Epub 2023 Sep 12. Angiology. 2024. PMID: 37699402 Review.
The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.
Gragnano F, Sperlongano S, Golia E, Natale F, Bianchi R, Crisci M, Fimiani F, Pariggiano I, Diana V, Carbone A, Cesaro A, Concilio C, Limongelli G, Russo M, Calabrò P. Gragnano F, et al. Among authors: golia e. Mediators Inflamm. 2017;2017:5620314. doi: 10.1155/2017/5620314. Epub 2017 May 28. Mediators Inflamm. 2017. PMID: 28634421 Free PMC article. Review.
63 results